Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Prosus NV (PRX.AS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-03-3022.9444.504Buy
2022-04-1920.5934.869Buy
2022-05-2320.4434.41Buy
2022-07-2131.7341.292Buy
2022-10-1724.5041.751Buy
2022-10-2720.0134.41Buy
2022-11-0423.0033.034Buy
2022-11-1727.7235.328Buy
2023-02-2231.6344.00Buy
2023-11-2230.2846.00Buy
2024-05-0633.6750.00Buy
2024-06-2633.9355.00Buy
2024-10-1839.3465.00Buy
2024-12-0339.1869.00Buy
2025-05-0243.2271.00Buy

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.